Altrinsic Global Advisors LLC Aerie Pharmaceuticals Inc Transaction History

Altrinsic Global Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.64 - $9.8 $1.52 Million - $2.65 Million	-270,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $339,600 - $498,899	30,000 Added 12.5%	270,000 $3.08 Million
Q4 2020 Feb 16, 2021	BUY	$9.12 - $14.49 $273,600 - $434,700	30,000 Added 14.29%	240,000 $3.24 Million
Q3 2020 Nov 16, 2020	BUY	$10.46 - $14.46 $627,600 - $867,600	60,000 Added 40.0%	210,000 $2.47 Million
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $360,000 - $483,899	30,000 Added 25.0%	150,000 $2.21 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $184,100 - $280,000	10,000 Added 9.09%	120,000 $2.31 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $434,550 - $723,150	15,000 Added 15.79%	110,000 $3.25 Million
Q4 2018 Feb 14, 2019	BUY	$33.0 - $60.04 $2.15 Million - $3.9 Million	65,000 Added 216.67%	95,000 $3.43 Million
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $1.68 Million - $2.22 Million	30,000 New	30,000 $1.85 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.